This inventor holds 7 USPTO granted patents. Top assignee: Astra Lakemedel Aktiebolag. Active years: 1980-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1987
Title: The Innovative Contributions of Alfons Misiorny
Introduction
Alfons Misiorny is a notable inventor based in Bandhagen, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral infections and cancer. With a total of seven patents to his name, Misiorny's work has the potential to impact both human and animal health.
Latest Patents
Among his latest patents is a method for combating virus infections. This method focuses on the selective treatment of virus infections in both animals and humans. It involves administering a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof. Another significant patent involves phosphonoformic acid esters and pharmaceutical compositions containing specific active ingredients. These compounds are designed to target various viral infections and cancer caused by viruses, showcasing Misiorny's innovative approach to medicine.
Career Highlights
Alfons Misiorny is currently associated with Astra Lakemedel Aktiebolag, where he continues to develop groundbreaking pharmaceutical solutions. His extensive research and development efforts have led to the creation of novel compounds and methods that hold promise for future medical applications.
Collaborations
Throughout his career, Misiorny has collaborated with esteemed colleagues such as Goran B Stening and Ake J Helgstrand. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective treatments.
Conclusion
Alfons Misiorny's contributions to the field of pharmaceuticals are noteworthy and impactful. His innovative patents and collaborative efforts position him as a significant figure in the ongoing fight against viral infections and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
